Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 29-Mar-24 9:00 PM View:  | MannKind Corp. (MNKD) | 27-Mar-24 | Payment of Exercise | 17,084 | $4.63 | $79,098.90 | (6%) 263.44K to 246.35K | |
| 05-Feb-24 6:00 AM View: | MannKind Corp. (MNKD) | 04-Feb-24 | Grant | 15,290 | $3.27 | $49,998.30 | 6% 248.15K to 263.44K | |
| 05-Feb-24 6:00 AM View: | MannKind Corp. (MNKD) | 31-Dec-23 | Grant | 711 | $3.09 | $2,196.99 | < 1% 247.43K to 248.15K | |
| 26-May-23 9:00 PM View: | MannKind Corp. (MNKD) | 25-May-23 | Grant | 23,250 | -- | -- | 10% 224.18K to 247.43K | |
| 24-May-23 9:00 PM View: | MannKind Corp. (MNKD) | 22-May-23 | Grant | 210,000 | -- | -- | 1481% 14.18K to 224.18K | |
| 15-May-23 5:01 PM View: | MannKind Corp. (MNKD) | 15-May-23 | Grant | 14,184 | $4.23 | $59,998.30 | 100% 0 to 14.18K | (2%) |
| 07-Sep-22 8:00 AM View: | Acorda Therapeutics, Inc. (ACOR) | 03-Sep-22 | Payment of Exercise | 1,511 | $0.40 | $601.38 | (12%) 12.22K to 10.71K | |
| 08-Sep-21 7:21 AM View: | Acorda Therapeutics, Inc. (ACOR) | 03-Sep-21 | Payment of Exercise | 1,511 | $4.38 | $6,618.18 | (11%) 13.73K to 12.22K | 4% |
| 05-Mar-21 6:36 PM View: | Acorda Therapeutics, Inc. (ACOR) | 03-Mar-21 | Grant | 11,125 | -- | -- | 427% 2.61K to 13.73K | |
| 21-Sep-20 8:35 AM View: | Acorda Therapeutics, Inc. (ACOR) | 17-Sep-20 | Grant | 3,015 | -- | -- | 24% 12.62K to 15.64K | |
| 04-Dec-19 7:51 AM View: | Acorda Therapeutics, Inc. (ACOR) | 02-Dec-19 | Market Sale (Planned) | 1,513 | $1.60 | $2,421.10 | (11%) 14.14K to 12.62K | 54% |
| 12-Mar-19 4:23 PM View: | Acorda Therapeutics, Inc. (ACOR) | 08-Mar-19 | Grant | 9,045 | -- | -- | 178% 5.09K to 14.14K | |
| 25-Feb-19 4:19 PM View: | Acorda Therapeutics, Inc. (ACOR) | 22-Feb-19 | Market Sale | 761 | $13.18 | $10,028.20 | (13%) 5.85K to 5.09K | 94% |
| 27-Dec-18 8:14 AM View: | Acorda Therapeutics, Inc. (ACOR) | 22-Dec-18 | Grant | 2,200 | -- | -- | 60% 3.65K to 5.85K | |
| 06-Dec-18 8:31 AM View: | Acorda Therapeutics, Inc. (ACOR) | 03-Dec-18 | Market Sale (Planned) | 5,191 | $20.56 | $106,737.00 | (77%) 6.76K to 1.57K | 96% |
| 07-Nov-18 4:11 PM View: | Acorda Therapeutics, Inc. (ACOR) | 05-Nov-18 | Payment of Exercise | 747 | $20.28 | $15,149.20 | (10%) 7.51K to 6.76K | 96% |
| 12-Sep-18 4:19 PM View: | Acorda Therapeutics, Inc. (ACOR) | 10-Sep-18 | Grant | 2,200 | -- | -- | 41% 5.31K to 7.51K | |
| 02-Jul-18 7:52 AM View: | Acorda Therapeutics, Inc. (ACOR) | 28-Jun-18 | Market Sale (Planned) | 5,859 | $27.84 | $163,140.00 | (52%) 11.16K to 5.31K | 97% |
| 12-Jun-18 7:40 AM View: | Acorda Therapeutics, Inc. (ACOR) | 08-Jun-18 | Option Exercise | 24,375 | $16.50 | $402,188.00 | 218% 11.16K to 35.54K | |
| 12-Jun-18 7:40 AM View: | Acorda Therapeutics, Inc. (ACOR) | 08-Jun-18 | Market Option Sale (Planned) | 24,375 | $35.00 | $853,125.00 | (69%) 35.54K to 11.16K | 98% |
| 22-May-18 4:35 PM View: | Acorda Therapeutics, Inc. (ACOR) | 18-May-18 | Market Sale (Planned) | 7,288 | $23.67 | $172,471.00 | (39%) 18.45K to 11.16K | 97% |
| 12-Mar-18 8:36 AM View: | Acorda Therapeutics, Inc. (ACOR) | 08-Mar-18 | Payment of Exercise | 2,085 | $25.65 | $53,480.20 | (10%) 20.54K to 18.45K | 97% |
| 26-Feb-18 8:37 AM View: | Acorda Therapeutics, Inc. (ACOR) | 22-Feb-18 | Grant | 5,859 | -- | -- | 40% 14.68K to 20.54K | |
| 05-Dec-17 7:44 AM View: | Acorda Therapeutics, Inc. (ACOR) | 01-Dec-17 | Market Sale (Planned) | 1,670 | $20.53 | $34,288.90 | (10%) 16.35K to 14.68K | 96% |
| 03-Mar-17 4:36 PM View: | Acorda Therapeutics, Inc. (ACOR) | 01-Mar-17 | Grant | 4,400 | -- | -- | 37% 11.95K to 16.35K | |
| 05-Dec-16 5:14 PM View: | Acorda Therapeutics, Inc. (ACOR) | 01-Dec-16 | Market Sale (Planned) | 2,429 | $20.74 | $50,381.10 | (17%) 14.38K to 11.95K | 96% |
| 23-Dec-15 9:16 AM View: | Acorda Therapeutics, Inc. (ACOR) | 22-Dec-15 | Option Exercise | 7,113 | $22.06 | $156,913.00 | 49% 14.38K to 21.49K | |
| 23-Dec-15 9:16 AM View: | Acorda Therapeutics, Inc. (ACOR) | 22-Dec-15 | Market Option Sale (Planned) | 7,113 | $42.04 | $299,063.00 | (33%) 21.49K to 14.38K | 98% |
| 21-Dec-15 4:15 PM View: | Acorda Therapeutics, Inc. (ACOR) | 17-Dec-15 | Option Exercise | 14,229 | $22.06 | $313,892.00 | 99% 14.38K to 28.61K | |
| 21-Dec-15 4:15 PM View: | Acorda Therapeutics, Inc. (ACOR) | 17-Dec-15 | Market Option Sale (Planned) | 14,229 | $40.00 | $569,160.00 | (50%) 28.61K to 14.38K | 98% |
| 03-Dec-15 4:44 PM View: | Acorda Therapeutics, Inc. (ACOR) | 01-Dec-15 | Market Sale (Planned) | 7,106 | $38.06 | $270,481.00 | (33%) 21.48K to 14.38K | 98% |
| 06-Mar-15 6:31 PM View: | Acorda Therapeutics, Inc. (ACOR) | 04-Mar-15 | Grant | 6,323 | -- | -- | 42% 15.16K to 21.48K | |
| 03-Dec-14 9:20 PM View: | Acorda Therapeutics, Inc. (ACOR) | 01-Dec-14 | Market Sale (Planned) | 3,242 | $35.58 | $115,344.00 | (18%) 18.4K to 15.16K | 98% |
| 07-Mar-14 4:24 PM View: | Acorda Therapeutics, Inc. (ACOR) | 05-Mar-14 | Grant | 6,000 | -- | -- | 48% 12.4K to 18.4K | |
| 09-Dec-13 4:02 PM View: | Acorda Therapeutics, Inc. (ACOR) | 05-Dec-13 | Market Sale (Planned) | 8,797 | $31.81 | $279,830.00 | (41%) 21.2K to 12.4K | 98% |
| 04-Dec-13 4:59 PM View: | Acorda Therapeutics, Inc. (ACOR) | 02-Dec-13 | Market Sale (Planned) | 6,603 | $33.52 | $221,319.00 | (24%) 27.8K to 21.2K | 98% |
| 25-Nov-13 5:55 PM View: | Acorda Therapeutics, Inc. (ACOR) | 22-Nov-13 | Market Sale (Planned) | 10,949 | $33.72 | $369,206.00 | (28%) 38.75K to 27.8K | 98% |
| 08-Mar-13 7:08 AM View: | Acorda Therapeutics, Inc. (ACOR) | 06-Mar-13 | Grant | 7,100 | -- | -- | 22% 31.65K to 38.75K | |
| 05-Dec-12 4:23 PM View: | Acorda Therapeutics, Inc. (ACOR) | 04-Dec-12 | Market Sale (Planned) | 4,364 | $24.58 | $107,259.00 | (12%) 36.02K to 31.65K | 97% |
| 19-Mar-12 4:05 PM View: | Acorda Therapeutics, Inc. (ACOR) | 15-Mar-12 | Grant | 9,000 | -- | -- | 33% 27.02K to 36.02K | |
| 05-Dec-11 3:57 PM View: | Acorda Therapeutics, Inc. (ACOR) | 01-Dec-11 | Market Sale (Planned) | 4,364 | $22.91 | $99,979.20 | (14%) 31.38K to 27.02K | 97% |
| 07-Mar-11 4:15 PM View: | Acorda Therapeutics, Inc. (ACOR) | 03-Mar-11 | Grant | 10,313 | -- | -- | 49% 21.07K to 31.38K | |
| 03-Dec-10 4:00 PM View: | Acorda Therapeutics, Inc. (ACOR) | 01-Dec-10 | Market Sale (Planned) | 3,933 | $26.53 | $104,342.00 | (16%) 25.0K to 21.07K | 97% |